These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 10961808)
41. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma. Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL Cancer Res; 2007 Sep; 67(18):8865-73. PubMed ID: 17875728 [TBL] [Abstract][Full Text] [Related]
42. Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck. Kim JW; Tsukishiro T; Johnson JT; Whiteside TL Clin Cancer Res; 2004 Aug; 10(15):5101-10. PubMed ID: 15297413 [TBL] [Abstract][Full Text] [Related]
43. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer. Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310 [TBL] [Abstract][Full Text] [Related]
44. Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma. Heimdal JH; Aarstad HJ; Olofsson J Laryngoscope; 2000 Mar; 110(3 Pt 1):402-7. PubMed ID: 10718427 [TBL] [Abstract][Full Text] [Related]
45. Infiltrating CD57+ inflammatory cells in head and neck squamous cell carcinoma: clinicopathological analysis and prognostic significance. Fraga CA; de Oliveira MV; Domingos PL; Botelho AC; Guimarães AL; Teixeira-Carvalho A; Correa-Oliveira R; De Paula AM Appl Immunohistochem Mol Morphol; 2012 May; 20(3):285-90. PubMed ID: 22505010 [TBL] [Abstract][Full Text] [Related]
46. Serum IL10 and circulating CD4(+) CD25(high) regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma. Alhamarneh O; Agada F; Madden L; Stafford N; Greenman J Head Neck; 2011 Mar; 33(3):415-23. PubMed ID: 20645289 [TBL] [Abstract][Full Text] [Related]
47. Serum IL10, IL12 and circulating CD4+CD25high T regulatory cells in relation to long-term clinical outcome in head and neck squamous cell carcinoma patients. Green VL; Irune E; Prasai A; Alhamarneh O; Greenman J; Stafford ND Int J Oncol; 2012 Mar; 40(3):833-9. PubMed ID: 22075762 [TBL] [Abstract][Full Text] [Related]
48. Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck. Hoffmann TK; Müller-Berghaus J; Ferris RL; Johnson JT; Storkus WJ; Whiteside TL Clin Cancer Res; 2002 Jun; 8(6):1787-93. PubMed ID: 12060618 [TBL] [Abstract][Full Text] [Related]
49. Blood transfusions and phenotypic immune profile in head and neck cancer patients undergoing surgical resection. MacRae JD; Lampe H; Banerjee D J Otolaryngol; 1991 Oct; 20(5):310-4. PubMed ID: 1960784 [TBL] [Abstract][Full Text] [Related]
50. Spontaneous rosette formation and rosette inhibition assays in patients with squamous cell carcinoma of the head and neck. Deegan MJ; Coulthard SW Cancer; 1977 May; 39(5):2137-41. PubMed ID: 322852 [TBL] [Abstract][Full Text] [Related]
51. Expression of IL-10 and IL-10 receptors on peripheral blood lymphocytes and monocytes in human head and neck squamous cell carcinoma. Kato H; Whiteside TL Tokai J Exp Clin Med; 2011 Dec; 36(4):144-51. PubMed ID: 22167499 [TBL] [Abstract][Full Text] [Related]
52. Circulating tumour cells in metastatic head and neck cancers. Kulasinghe A; Perry C; Jovanovic L; Nelson C; Punyadeera C Int J Cancer; 2015 Jun; 136(11):2515-23. PubMed ID: 25111594 [TBL] [Abstract][Full Text] [Related]
53. Correlation of preoperative immunologic test results with recurrence in patients with head and neck cancer. Ryan RE; Neel HB; Ritts RE Otolaryngol Head Neck Surg (1979); 1980; 88(1):58-63. PubMed ID: 6967203 [TBL] [Abstract][Full Text] [Related]
54. In vivo effects of thymostimulin treatment on monocyte polarization, dendritic cell clustering and serum p15E-like trans-membrane factors in operable head and neck squamous cell carcinoma patients. Kerrebijn JD; Simons PJ; Tas M; Balm AJ; Drexhage HA Eur Arch Otorhinolaryngol; 1995; 252(7):409-16. PubMed ID: 8562036 [TBL] [Abstract][Full Text] [Related]
55. T-lymphocytes and survival of head and neck squamous cell carcinoma. Mason JM; Kitchens GG; Eastham RJ; Jennings BR Arch Otolaryngol; 1977 Apr; 103(4):223-7. PubMed ID: 300622 [TBL] [Abstract][Full Text] [Related]
56. T-lymphocyte levels in the peripheral blood of patients with cancer of the head and neck. Olkowski ZL; Wilkins SA Am J Surg; 1975 Oct; 130(4):440-4. PubMed ID: 1080960 [TBL] [Abstract][Full Text] [Related]
57. Inverse immunological responses induced by allergic rhinitis and head and neck squamous cell carcinoma. Millrud CR; Hylander T; Kumlien Georen S; Kågedal Å; Winqvist O; Cardell LO PLoS One; 2014; 9(1):e86796. PubMed ID: 24466243 [TBL] [Abstract][Full Text] [Related]
58. Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck. De Costa AM; Schuyler CA; Walker DD; Young MR Cancer Immunol Immunother; 2012 Jun; 61(6):927-39. PubMed ID: 22116344 [TBL] [Abstract][Full Text] [Related]
59. A multicellular tumor spheroid model of cellular immunity against head and neck cancer. Sacks PG; Taylor DL; Racz T; Vasey T; Oke V; Schantz SP Cancer Immunol Immunother; 1990; 32(3):195-200. PubMed ID: 2289213 [TBL] [Abstract][Full Text] [Related]
60. T-lymphocytes phenotype and functions in patients with head and neck cancer. Pierri I; Cordone G; Rogna S; Piccardo C; Barabino A; Indiveri F Laryngoscope; 1985 May; 95(5):577-81. PubMed ID: 3157845 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]